Trial Profile
AY4166 Phase III Long-term Study in Type 2 Diabetes Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Nateglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Ajinomoto Pharma
- 09 Jun 2016 New trial record